How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification. [electronic resource]
Producer: 20080422Description: 357-62 p. digitalISSN:- 0340-6245
- Adenosine Diphosphate -- analogs & derivatives
- Aged
- Algorithms
- Angioplasty, Balloon, Coronary -- adverse effects
- Aspirin -- administration & dosage
- Blood Platelets -- drug effects
- Cardiovascular Diseases -- blood
- Clinical Protocols
- Clopidogrel
- Coronary Artery Disease -- blood
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Monitoring -- methods
- Drug Resistance
- Feasibility Studies
- Female
- Humans
- Male
- Middle Aged
- Pilot Projects
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Function Tests
- Prospective Studies
- Purinergic P2 Receptor Antagonists
- Receptors, Purinergic P2 -- blood
- Receptors, Purinergic P2Y12
- Stents
- Ticlopidine -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.